https://www.selleckchem.com/products/kn-62.html
o and TMPRSS2. We hope to provide new horizons for researchers worldwide searching for more effective drugs against this devastating agent. Chronic kidney disease (CKD) is characterized by persistent low-grade inflammation. Soluble CD14 (sCD14) is involved in many pathological conditions including inflammation and atherosclerosis. The present study aimed to assess the relation between sCD14 levels, subclinical atherosclerosis (SCA), inflammation and mortality in Egyptian hemodialysis (HD) patients. The present longitudinal study included